Header image

PAEDIATRICS: Level 3 and Level 4 devices for diagnosis of sleep disordered breathing in children with neurodisability: considerations, challenges and comparisons with PSG

Tracks
Track 2
Thursday, October 9, 2025
3:30 PM - 5:00 PM

Details

This symposium will discuss alternatives to in lab level 1 PSG for children with neurodisability who are one of the largest sub-populations of children who undergo evaluation for SDB in tertiary centres. Comparison data from clinical trials and pilot studies undertaken with level 2 and 3 devices will be presented, focusing on the specific benefits and challenges with these devices in children with neurodisability.


Speaker

Dr Adelaide Withers
Respiratory And Sleep Consultant
Perth Children's Hospital

Comparison with level 1 PSG: Home level 2 PSG for the diagnosis of sleep disordered breathing in children with neurodisability

3:30 PM - 3:47 PM

Biography

Anne-Marie Adams

Level 3 and level 4 devices for diagnosis of SDB in children - what's available and what's the evidence in children?

3:47 PM - 4:04 PM

Biography

Moya Vandeleur
Royal Children's Hospital Melbourne

Pros and cons of level 3 and 4 devices in children with neurodisability, including consumer perspectives

4:04 PM - 4:21 PM

Biography

Andrew Collaro

Comparison with level 1 PSG: (1) Machine-learning pulse oximetry analysis and (2) mandibular movement monitoring for the detection of SDB in children with neurodisability

4:21 PM - 4:38 PM

Biography

Agenda Item Image
Assoc Prof Jasneek Chawla
Paediatric Respiratory And Sleep Specialist
Queensland Children’s Hospital

Comparison with level 1 PSG: Results of an Australian multi-centre clinical trial of the Sonomat Sleep Mat System for diagnosis of SDB in children with neurodisability

4:38 PM - 4:55 PM

Biography

Karen Waters

Chair

Biography

Dr Ajay Kevat
Senior Medical Officer
Queensland Children's Hospital

Chair

Biography

loading